These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 10455445

  • 1. Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector.
    Reynolds P, Dmitriev I, Curiel D.
    Gene Ther; 1999 Jul; 6(7):1336-9. PubMed ID: 10455445
    [Abstract] [Full Text] [Related]

  • 2. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob.
    Mizuguchi H, Koizumi N, Hosono T, Utoguchi N, Watanabe Y, Kay MA, Hayakawa T.
    Gene Ther; 2001 May; 8(9):730-5. PubMed ID: 11406768
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon.
    Kurachi S, Koizumi N, Sakurai F, Kawabata K, Sakurai H, Nakagawa S, Hayakawa T, Mizuguchi H.
    Gene Ther; 2007 Feb; 14(3):266-74. PubMed ID: 17006548
    [Abstract] [Full Text] [Related]

  • 5. Targeting of adenovirus vectors carrying a tumor cell-specific peptide: in vitro and in vivo studies.
    Rittner K, Schreiber V, Erbs P, Lusky M.
    Cancer Gene Ther; 2007 May; 14(5):509-18. PubMed ID: 17318198
    [Abstract] [Full Text] [Related]

  • 6. Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area.
    Kügler S, Kilic E, Bähr M.
    Gene Ther; 2003 Feb; 10(4):337-47. PubMed ID: 12595892
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of transgene expression mediated by several Fiber-modified adenovirus vectors in trophoblast cells.
    Koizumi N, Kondoh M, Mizuguchi H, Nakanishi T, Masuyama A, Ida F, Fujii M, Hayakawa T, Nakashima E, Tanaka K, Watanabe Y.
    Placenta; 2005 Nov; 26(10):729-34. PubMed ID: 16226122
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Uptake of adenoviral vectors via fibroblast growth factor receptors involves intracellular pathways that differ from the targeting ligand.
    Hoganson DK, Sosnowski BA, Pierce GF, Doukas J.
    Mol Ther; 2001 Jan; 3(1):105-12. PubMed ID: 11162317
    [Abstract] [Full Text] [Related]

  • 11. Modifications in adenoviral coat fiber proteins and transcriptional regulatory sequences enhance transgene expression.
    Perlman H, Liu H, Georganas C, Woods JM, Amin MA, Koch AE, Wickham T, Kovesdi I, Mano T, Walsh K, Pope RM.
    J Rheumatol; 2002 Aug; 29(8):1593-600. PubMed ID: 12180715
    [Abstract] [Full Text] [Related]

  • 12. Genetic targeting strategies for adenovirus.
    Noureddini SC, Curiel DT.
    Mol Pharm; 2005 Aug; 2(5):341-7. PubMed ID: 16196486
    [Abstract] [Full Text] [Related]

  • 13. Promoters influence the kinetics of transgene expression following adenovector gene delivery.
    Chen P, Tian J, Kovesdi I, Bruder JT.
    J Gene Med; 2008 Feb; 10(2):123-31. PubMed ID: 18064718
    [Abstract] [Full Text] [Related]

  • 14. Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma.
    Barker SD, Dmitriev IP, Nettelbeck DM, Liu B, Rivera AA, Alvarez RD, Curiel DT, Hemminki A.
    Gene Ther; 2003 Jul; 10(14):1198-204. PubMed ID: 12833129
    [Abstract] [Full Text] [Related]

  • 15. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.
    Van Linthout S, Lusky M, Collen D, De Geest B.
    Gene Ther; 2002 Nov; 9(22):1520-8. PubMed ID: 12407424
    [Abstract] [Full Text] [Related]

  • 16. Comparison of high-capacity and first-generation adenoviral vector gene delivery to murine muscle in utero.
    Bilbao R, Reay DP, Wu E, Zheng H, Biermann V, Kochanek S, Clemens PR.
    Gene Ther; 2005 Jan; 12(1):39-47. PubMed ID: 15483668
    [Abstract] [Full Text] [Related]

  • 17. Adenovirus vectors targeting alphaV integrin or heparan sulfate receptors display different distribution of transgene activity after intramuscular injection.
    Cirielli C, Serino F, Straino S, Toietta G, Abeni D, Ventoruzzo G, Orlando G, Mazzanti P, Melillo G, Whickham TJ, Kovesdi I, Biglioli P, Gaetano C, Capogrossi MC.
    J Gene Med; 2004 Mar; 6(3):309-16. PubMed ID: 15026992
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL.
    Harui A, Roth MD, Kiertscher SM, Mitani K, Basak SK.
    Gene Ther; 2004 Nov; 11(22):1617-26. PubMed ID: 15295617
    [Abstract] [Full Text] [Related]

  • 20. Oncolytic adenoviral vector carrying the cytosine deaminase gene for melanoma gene therapy.
    Liu Y, Deisseroth A.
    Cancer Gene Ther; 2006 Sep; 13(9):845-55. PubMed ID: 16710344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.